InhibTide™ is synthesized using solid-phase methods or Cholesterol-PEG-Maleimide methods, which involve the synthesis of peptides or appropriate tagging modifications. This synthesis process enables effective inhibition of viral activity. These peptides demonstrate notable antiviral activity and low cytotoxicity, they can be used as suitable positive controls in antiviral activity research.